[Progress in oral antidiabetic therapy].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000818:Animals; D001381:Azepines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D001381:Azepines; D007004:Hypoglycemic Agents; D010080:Oxazoles; D013453:Sulfonylurea Compounds
Progrès dans la thérapeutique anti-diabétique orale